UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Generation of novel respiratory syncytial virus vaccine candidate antigens that can induce high levels of prefusion-specific antibodies

Journal of bioscience and bioengineering, 2024-08, Vol.138 (2), p.127-136

2024

Volltextzugriff (PDF)

Mucosal delivery of a prefusogenic-F, glycoprotein, and matrix proteins-based virus-like particle respiratory syncytial virus vaccine induces protective immunity as evidenced by challenge studies in mice

Virology (New York, N.Y.), 2024-10, Vol.598, p.110194, Article 110194

2024

Volltextzugriff (PDF)

Immunological Lessons from Respiratory Syncytial Virus Vaccine Development

Immunity (Cambridge, Mass.), 2019-09, Vol.51 (3), p.429-442

2019

Volltextzugriff (PDF)

Formulation of the respiratory syncytial virus fusion protein with a polymer-based combination adjuvant promotes transient and local innate immune responses and leads to improved adaptive immunity

Vaccine, 2016-09, Vol.34 (42), p.5114-5124

2016

Volltextzugriff (PDF)

Immunology of bovine respiratory syncytial virus in calves

Molecular immunology, 2015-07, Vol.66 (1), p.48-56

2015

Volltextzugriff (PDF)

Novel antigens for RSV vaccines

Current opinion in immunology, 2015-08, Vol.35, p.30-38

2015

Volltextzugriff (PDF)

Upper and lower respiratory tract correlates of protection against respiratory syncytial virus following vaccination of nonhuman primates

Cell host & microbe, 2022-01, Vol.30 (1), p.41-52.e5

2022

Volltextzugriff (PDF)

Vaccination against respiratory syncytial virus in pregnancy: a suitable tool to combat global infant morbidity and mortality?

The Lancet infectious diseases, 2016-08, Vol.16 (8), p.e153-e163

2016

Volltextzugriff (PDF)

A single, low dose of a cGMP recombinant BCG vaccine elicits protective T cell immunity against the human respiratory syncytial virus infection and prevents lung pathology in mice

Vaccine, 2017-02, Vol.35 (5), p.757-766

2017

Volltextzugriff (PDF)

Combined virus-like particle and fusion protein-encoding DNA vaccination of cotton rats induces protection against respiratory syncytial virus without causing vaccine-enhanced disease

Virology (New York, N.Y.), 2016-07, Vol.494, p.215-224

2016

Volltextzugriff (PDF)

Estimating the impact of multiple immunization products on medically-attended respiratory syncytial virus (RSV) infections in infants

Vaccine, 2020-01, Vol.38 (2), p.251-257

2020

Volltextzugriff (PDF)

VLPs generated by the fusion of RSV-F or hMPV-F glycoprotein to HIV-Gag show improved immunogenicity and neutralizing response in mice

Vaccine, 2024-05, Vol.42 (15), p.3474-3485

2024

Volltextzugriff (PDF)

Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responses

Immunity (Cambridge, Mass.), 2021-04, Vol.54 (4), p.769-780.e6

2021

Volltextzugriff (PDF)

Antibody levels against respiratory syncytial virus fusion protein conformations and lack of association with life-threatening infection in previously healthy infants

Vaccine, 2024-11, Vol.42 (25), p.126119, Article 126119

2024

Volltextzugriff (PDF)

Meeting report: WHO consultation on Respiratory Syncytial Virus (RSV) vaccine development, Geneva, 25–26 April 2016

Vaccine, 2019-11, Vol.37 (50), p.7355-7362

2019

Volltextzugriff (PDF)

A unique combination adjuvant modulates immune responses preventing vaccine-enhanced pulmonary histopathology after a single dose vaccination with fusion protein and challenge with respiratory syncytial virus

Virology (New York, N.Y.), 2019-08, Vol.534, p.1-13

2019

Volltextzugriff (PDF)

Summary of the Vaccines and Related Biological Products Advisory Committee meeting held to consider evaluation of vaccine candidates for the prevention of respiratory syncytial virus disease in RSV-naïve infants

Vaccine, 2020-01, Vol.38 (2), p.101-106

2020

Volltextzugriff (PDF)

Immunization with an adjuvanted low-energy electron irradiation inactivated respiratory syncytial virus vaccine shows immunoprotective activity in mice

Vaccine, 2018-03, Vol.36 (12), p.1561-1569

2018

Volltextzugriff (PDF)

Recombinant live attenuated influenza vaccine viruses carrying CD8 T-cell epitopes of respiratory syncytial virus protect mice against both pathogens without inflammatory disease

Antiviral research, 2019-08, Vol.168, p.9-17

2019

Volltextzugriff (PDF)

Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: a phase 3 randomised double-blind placebo-controlled trial

The Lancet infectious diseases, 2015-12, Vol.15 (12), p.1398-1408

2015

Volltextzugriff (PDF)

Recombinant influenza virus carrying the conserved domain of respiratory syncytial virus (RSV) G protein confers protection against RSV without inflammatory disease

Virology (New York, N.Y.), 2015-02, Vol.476, p.217-225

2015

Volltextzugriff (PDF)

Enhanced immune responses and protection by vaccination with respiratory syncytial virus fusion protein formulated with CpG oligodeoxynucleotide and innate defense regulator peptide in polyphosphazene microparticles

Vaccine, 2012-07, Vol.30 (35), p.5206-5214

2012

Volltextzugriff (PDF)

Animal models of respiratory syncytial virus infection

Vaccine, 2017-01, Vol.35 (3), p.469-480

Taylor, Geraldine

2017

Volltextzugriff (PDF)

Asthma and viral infections: An intricate relationship

Annals of allergy, asthma, & immunology, 2019-10, Vol.123 (4), p.352-358

2019

Volltextzugriff (PDF)

Potential impact of a maternal vaccine for RSV: A mathematical modelling study

Vaccine, 2017-10, Vol.35 (45), p.6172-6179

2017

Volltextzugriff (PDF)

1 – 25 von 1.439

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.424)
Mit Volltextzugriff
(1.380)

Publikationsform

Artikel
(1.439)

Sprache

Englisch
(1.412)
Französisch
(17)
Spanisch
(10)

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.321)
Life Sciences & Biomedicine
(1.319)
Respiratory Syncytial Virus
(967)
Humans
(939)
Immunology
(811)
Animals
(651)
Female
(514)
Biological And Medical Sciences
(471)
Virology
(429)
Respiratory Syncytial Viruses - Immunology
(413)
Respiratory Syncytial Virus Infections - Immunology
(411)
Medicine, Research & Experimental
(404)
Research & Experimental Medicine
(404)
Infant
(368)
Fundamental And Applied Biological Sciences. Psychology
(347)
Microbiology
(342)
Vaccines
(338)
Respiratory Syncytial Virus Infections - Prevention & Control
(330)
Male
(308)
Mice
(306)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Generation of novel respiratory syncytial virus vaccine candidate antigens that can induce high levels of prefusion-specific antibodies

Mucosal delivery of a prefusogenic-F, glycoprotein, and matrix proteins-based virus-like particle respiratory syncytial virus vaccine induces protective immunity as evidenced by challenge studies in mice

Immunological Lessons from Respiratory Syncytial Virus Vaccine Development

Formulation of the respiratory syncytial virus fusion protein with a polymer-based combination adjuvant promotes transient and local innate immune responses and leads to improved adaptive immunity

Immunology of bovine respiratory syncytial virus in calves

Novel antigens for RSV vaccines

Upper and lower respiratory tract correlates of protection against respiratory syncytial virus following vaccination of nonhuman primates

Vaccination against respiratory syncytial virus in pregnancy: a suitable tool to combat global infant morbidity and mortality?

A single, low dose of a cGMP recombinant BCG vaccine elicits protective T cell immunity against the human respiratory syncytial virus infection and prevents lung pathology in mice

Combined virus-like particle and fusion protein-encoding DNA vaccination of cotton rats induces protection against respiratory syncytial virus without causing vaccine-enhanced disease

Estimating the impact of multiple immunization products on medically-attended respiratory syncytial virus (RSV) infections in infants

VLPs generated by the fusion of RSV-F or hMPV-F glycoprotein to HIV-Gag show improved immunogenicity and neutralizing response in mice

Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responses

Antibody levels against respiratory syncytial virus fusion protein conformations and lack of association with life-threatening infection in previously healthy infants

Meeting report: WHO consultation on Respiratory Syncytial Virus (RSV) vaccine development, Geneva, 25–26 April 2016

A unique combination adjuvant modulates immune responses preventing vaccine-enhanced pulmonary histopathology after a single dose vaccination with fusion protein and challenge with respiratory syncytial virus

Summary of the Vaccines and Related Biological Products Advisory Committee meeting held to consider evaluation of vaccine candidates for the prevention of respiratory syncytial virus disease in RSV-naïve infants

Immunization with an adjuvanted low-energy electron irradiation inactivated respiratory syncytial virus vaccine shows immunoprotective activity in mice

Recombinant live attenuated influenza vaccine viruses carrying CD8 T-cell epitopes of respiratory syncytial virus protect mice against both pathogens without inflammatory disease

Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: a phase 3 randomised double-blind placebo-controlled trial

Recombinant influenza virus carrying the conserved domain of respiratory syncytial virus (RSV) G protein confers protection against RSV without inflammatory disease

Enhanced immune responses and protection by vaccination with respiratory syncytial virus fusion protein formulated with CpG oligodeoxynucleotide and innate defense regulator peptide in polyphosphazene microparticles

Animal models of respiratory syncytial virus infection

Asthma and viral infections: An intricate relationship

Potential impact of a maternal vaccine for RSV: A mathematical modelling study

Aktive Filter

Suchergebnisse filtern